According to the latest report by IMARC Group, titled “Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033,” the global viscosupplementation market size reached USD 4.8 Billion in 2024. Viscosupplementation is a medical procedure commonly used to provide relief to individuals suffering from osteoarthritis. It involves the injection of a gel-like substance directly into the affected joint. The injected fluid acts as a lubricant, reducing friction between the bones and allowing for smooth movement. The aim of viscosupplementation is to supplement the diminished levels of hyaluronic acid in the affected joint, thereby improving joint mobility, reducing pain, and potentially delaying the need for more invasive treatments, such as joint replacement surgery. Additionally, it restores the rheological properties of the synovial fluids, resulting in mechanical, analgesic, anti-inflammatory, and chondroprotective benefits. As a result, it is widely used for the treatment of osteoarthritis in the hip, knee, and hand.
Global Viscosupplementation Market Trends:
The global market is majorly driven by the increasing prevalence of osteoarthritis among the masses. Along with this, with the growing elderly population, there is a greater need for treatments that can alleviate joint pain and improve mobility, thus propelling the demand for viscosupplementation. Moreover, the increased awareness about treatment options and patient education regarding the benefits of viscosupplementation is significantly supporting the market. Besides, changing lifestyles, including sedentary habits and participation in sports activities, are also strengthening the market as these injuries lead to the development of osteoarthritis, further impelling the demand for viscosupplementation as a treatment option. Apart from this, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscles, spine, and nerves, is impacting the market favorably. Furthermore, several major companies are heavily investing in developing new formulations with enhanced properties, longer-lasting effects, and improved patient outcomes, thus providing a boost to the market. Additionally, ongoing technological advancements in delivery systems, such as pre-filled syringes and autoinjectors, are acting as another growth-inducing factor. Looking forward, the market value is projected to reach USD 9.1 Billion by 2033, expanding at a CAGR of 7.05% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Types Covered | Single Injection, Three Injection, Five Injection |
Age Groups Covered | Adults, Geriatrics |
Distribution Channels Covered | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
Applications Covered | Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Others |
End Uses Covered | Hospitals, Orthopedic Clinics, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800